Nonallergic Rhinitis, Allergic Rhinitis, and Immunotherapy: Advances in the Last Decade

被引：31

作者：

Ponda, Punita ^{[1
,2
,3
,4
,12
]}

Carr, Tara ^{[5
,6
]}

Rank, Matthew A. ^{[7
,8
,9
]}

Bousquet, Jean ^{[10
,11
]}

机构：

[1] Northwell Hlth, Donald & Barbara Zucker Sch Med, Div Allergy & Immunol, Hofstra Northwell, Great Neck, NY 11021 USA

[2] Northwell Hlth, Donald & Barbara Zucker Sch Med, Dept Pediat, Hofstra Northwell, New Hyde Pk, NY USA

[3] Northwell Hlth Syst, Donald & Barbara Zucker Sch Med, Dept Med, Northwell Hlth,Hofstra Northwell, Manhasset, NY USA

[4] Northwell Hlth, Inst Hlth Syst Sci, Feinstein Inst Med Res, Manhasset, NY USA

[5] Univ Arizona, Asthma & Airway Dis Res Ctr, Tucson, AZ USA

[6] Univ Arizona, Dept Med, Sect Allergy & Immunol, Coll Med, Tucson, AZ USA

[7] Mayo Clin, Div Allergy Asthma & Clin Immunol, Phoenix, AZ USA

[8] Mayo Clin, Div Allergy Asthma & Clin Immunol, Scottsdale, AZ USA

[9] Phoenix Childrens Hosp, Div Pulmonol, Phoenix, AZ USA

[10] Univ Med Berlin, Berlin, Germany

[11] Free Univ Berlin, Berlin, Germany

[12] Northwell Hlth, Cohen Childrens Hosp New York, Donald & Barbara Zucker Sch Med, Div Allergy & Immunol,Hofstra Northwell, 865 Northern Blvd,Ste 101, Great Neck, North 11021, Haiti

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2023年 / 11卷 / 01期

关键词：

Allergic rhinitis; Nonallergic rhinitis; Immuno-therapy; Allergen immunotherapy; Digital health; Care pathway; Mobile Airways Sentinel NetworK; NASAL HYPERREACTIVITY; CLINICAL-RESPONSE; EAACI GUIDELINES; ASTHMA; RHINOCONJUNCTIVITIS; MANAGEMENT; SAFE; MECHANISMS; CHILDREN;

D O I：

10.1016/j.jaip.2022.09.010

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Chronic rhinitis encompassing both allergic and nonallergic rhinitis affects a significant portion of the population worldwide, having a great impact on patient quality of life, and associated comorbid conditions, with an important societal economic burden. Allergists are often the first to evaluate and treat allergic and nonallergic rhinitis, addressing the individual triggers of the disease as well as the patient-specific responses to these triggers. This review focuses on the advances that have been made in the diagnosis, management, and treatment of nonallergic and allergic rhinitis over the past 10 years, including specific allergen immunotherapy, care pathways, and digital health.(c) 2022 American Academy of Allergy, Asthma & Immunology (J Allergy Clin Immunol Pract 2023;11:35-42)

引用

页码：35 / 42

页数：8

共 92 条

[51] Allergen Immunotherapy and Tolerance [J].

Matsuoka, Tomokazu ;

Shamji, Mohamed H. ;

Durham, Stephen R. .

ALLERGOLOGY INTERNATIONAL, 2013, 62 (04) :403-413

[52] Findings from an Online Survey Assessing the Burden and Management of Seasonal Allergic Rhinoconjunctivitis in US Patients [J].

Meltzer, Eli O. ;

Farrar, Judith Rosen ;

Sennett, Cary .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (03) :779-+

[53] EAACI guidelines on allergen immunotherapy: Executive statement [J].

Muraro, A. ;

Roberts, G. ;

Halken, S. ;

Agache, I. ;

Angier, E. ;

Fernandez-Rivas, M. ;

van Wijk, R. Gerth ;

Jutel, M. ;

Lau, S. ;

Pajno, G. ;

Pfaar, O. ;

Ryan, D. ;

Sturm, G. J. ;

van Ree, R. ;

Varga, E. -M. ;

Bachert, C. ;

Calderon, M. ;

Canonica, G. W. ;

Durham, S. R. ;

Malling, H. J. ;

Wahn, U. ;

Sheikh, A. .

ALLERGY, 2018, 73 (04) :739-743

[54] Add-On Omalizumab for Inadequately Controlled Severe Pollinosis Despite Standard-of-Care: A Randomized Study [J].

Okubo, Kimihiro ;

Okano, Mitsuhiro ;

Sato, Norio ;

Tamaki, Yuko ;

Suzuki, Hiromi ;

Uddin, Alkaz ;

Fogel, Robert .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (09) :3130-+

[55] Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis [J].

Okubo, Kimihiro ;

Masuyama, Keisuke ;

Imai, Toru ;

Okamiya, Kazuhiro ;

Stage, Brian Sonne ;

Seitzberg, Dorthe ;

Konno, Akiyoshi .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (06) :1840-+

[56] Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial [J].

Park, Hye Jung ;

Kim, Sae-Hoon ;

Shin, Yoo Seob ;

Park, Chul Hwan ;

Cho, Eun-Suk ;

Choi, Seung Joon ;

Park, So Hyun ;

Jung, Joo Hyun ;

Kang, Il Gyu ;

Lee, Myoung Seok ;

Kim, Dae Woo ;

Lee, Sang Min ;

Yang, Min-Suk ;

Lee, Sang Pyo .

RESPIRATORY RESEARCH, 2021, 22 (01)

[57] Allergen Immunotherapy: Current and Future Trends [J].

Pavon-Romero, Gandhi F. ;

Parra-Vargas, Maria Itzel ;

Ramirez-Jimenez, Fernando ;

Melgoza-Ruiz, Esmeralda ;

Serrano-Perez, Nancy H. ;

Teran, Luis M. .

CELLS, 2022, 11 (02)

[58] Duration of allergen immunotherapy for inhalant allergy [J].

Penagos, Martin ;

Durham, Stephen R. .

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 19 (06) :594-605

[59] A randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patients [J].

Pfaar, O. ;

Nell, M. J. ;

Boot, J. D. ;

Versteeg, S. A. ;

van Ree, R. ;

Roger, A. ;

Riechelmann, H. ;

Sperl, A. ;

Elberink, J. N. G. Oude ;

Diamant, Z. ;

Bachert, C. .

ALLERGY, 2016, 71 (07) :967-976

[60] EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis [J].

Roberts, G. ;

Pfaar, O. ;

Akdis, C. A. ;

Ansotegui, I. J. ;

Durham, S. R. ;

van Wijk, R. Gerth ;

Halken, S. ;

Larenas-Linnemann, D. ;

Pawankar, R. ;

Pitsios, C. ;

Sheikh, A. ;

Worm, M. ;

Arasi, S. ;

Calderon, M. A. ;

Cingi, C. ;

Dhami, S. ;

Fauquert, J. L. ;

Hamelmann, E. ;

Hellings, P. ;

Jacobsen, L. ;

Knol, E. F. ;

Lin, S. Y. ;

Maggina, P. ;

Moesges, R. ;

Elberink, J. N. G. Oude ;

Pajno, G. B. ;

Pastorello, E. A. ;

Penagos, M. ;

Rotiroti, G. ;

Schmidt-Weber, C. B. ;

Timmermans, F. ;

Tsilochristou, O. ;

Varga, E. -M. ;

Wilkinson, J. N. ;

Williams, A. ;

Zhang, L. ;

Agache, I. ;

Angier, E. ;

Fernandez-Rivas, M. ;

Jutel, M. ;

Lau, S. ;

van Ree, R. ;

Ryan, D. ;

Sturm, G. J. ;

Muraro, A. .

ALLERGY, 2018, 73 (04) :765-798

← 1 2 3 4 5 6 7 8 9 10 →